🔗 Permalink

Inventor profile of:

Pieter Cullis

City:

Vancouver

Country:

Canada

Published Applications:

Last publication date:

2025-08-21

Top Assignees for applications by Pieter Cullis

The entities that hold a legal rights for patent applications filed by inventor Cullis Pieter:

The University of British Columbia 8 Vancouver, Canada
University of British Columbia 2 Vancouver, British Columbia, Canada
THE UNIVERSITY OF BRITISH COLUMBIA 2 Vancouver, British Columbia, Canada
The University of British Columbia 1 Vancouver, BC Canada
Inex Pharmaceuticals Corporation 1 Burnaby, Canada

Recent patent applications by Cullis Pieter

Pieter Cullis from Vancouver, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-08-21

US20250262158A1

Human necessities

NANO-IN-MICRO ENCAPSULATED siRNA DRY POWDER, METHOD FOR PRODUCING THE SAME AND USE OF A POWDER FORMULATION

#2 | 2025-07-10

US20250222113A1

Human necessities

Hybrid Lipid Nanoparticle Comprising an Inorganic Particle and an Agent of Interest

#3 | 2024-10-24

US20240350676A1

Human necessities

COMPOSITIONS AND SYSTEMS COMPRISING TRANSFECTION-COMPETENT VESICLES FREE OF ORGANIC-SOLVENTS AND DETERGENTS AND METHODS RELATED THERETO

#4 | 2024-10-17

US20240342315A1

Human necessities

COMPOSITIONS AND SYSTEMS COMPRISING TRANSFECTION-COMPETENT VESICLES FREE OF ORGANIC-SOLVENTS AND DETERGENTS AND METHODS RELATED THERETO

#5 | 2023-03-09

US20230073819A1

Human necessities

Compositions and systems comprising transfection-competent vesicles free of organic-solvents and detergents and methods related thereto

#6 | 2022-04-21

US20220118112A1

Human necessities

Compositions and systems comprising transfection-competent vesicles free of organic-solvents and detergents and methods related thereto

#7 | 2018-08-09

US20180221279A1

Human necessities

MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES

#8 | 2014-12-04

US20140356417A1

Human necessities

Modified drugs for use in liposomal nanoparticles

#9 | 2013-09-12

US20130236534A1

Human necessities

Modified drugs for use in liposomal nanoparticles

#10 | 2013-09-05

US20130230583A1

Human necessities

Modified drugs for use in liposomal nanoparticles

#11 | 2013-09-05

US20130230582A1

Human necessities

Modified drugs for use in liposomal nanoparticles

#12 | 2012-09-20

US20120237591A1

Human necessities

Modified drugs for use in liposomal nanoparticles

#13 | 2012-05-10

US20120114831A1

Human necessities

HIGH EFFICIENCY ENCAPSULATION OF CHARGED THERAPEUTIC AGENTS IN LIPID VESICLES

#14 | 2011-07-07

US20110165225A1

Human necessities

Modified drugs for use in liposomal nanoparticles

#15 | 2008-08-21

US20080200417A1

Human necessities

Lipid-encapsulated polyanionic nucleic acid

#16 | 2007-05-29

US10323248

Multivalent cationic lipids and methods of using same in the production of lipid particles

#17 | 2005-11-17

US20050255153A1

Human necessities

Lipid-encapsulated polyanionic nucleic acid

#18 | 2005-02-22

US9895480

Lipid-encapsulated polyanionic nucleic acid

#19 | 2005-01-13

US20050008689A1

Human necessities

High efficiency encapsulation of charged therapeutic agents in lipid vesicles

InventorID:

424237 ⎘